Geographical Variability in Mortality in Urban Areas: A Joint Analysis of 16 Causes of Death.

geographical inequalities mortality multivariate disease mapping urban areas

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
25 05 2021
Historique:
received: 26 04 2021
revised: 21 05 2021
accepted: 22 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 7 2021
Statut: epublish

Résumé

The geographical distribution of mortality has frequently been studied. Nevertheless, those studies often consider isolated causes of death. In this work, we aim to study the geographical distribution of mortality in urban areas, in particular, in 26 Spanish cities. We perform an overall study of 16 causes of death, considering that their geographical patterns could be dependent and estimating the dependence between the causes of death. We study the deaths in these 26 cities during the period 1996-2015 at the census tract level. A multivariate disease mapping model is used in order to solve the potential small area estimation problems that these data could show. We find that most of the geographical patterns found show positive correlations. This suggests the existence of a transversal geographical pattern, common to most causes of deaths, which determines those patterns to a higher/lower extent depending on each disease. The causes of death that exhibit that underlying pattern in a more prominent manner are chronic obstructive pulmonary disease (COPD), lung cancer, and cirrhosis for men and cardiovascular diseases and dementias for women. Such findings are quite consistent for most of the cities in the study. The high positive correlation found between geographical patterns reflects the existence of both high and low-risk areas in urban settings, in general terms for nearly all the causes of death. Moreover, the high-risk areas found often coincide with neighborhoods known for their high deprivation. Our results suggest that dependence among causes of death is a key aspect to be taken into account when mapping mortality, at least in urban contexts.

Identifiants

pubmed: 34070635
pii: ijerph18115664
doi: 10.3390/ijerph18115664
pmc: PMC8197960
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Soc Sci Med. 2012 Apr;74(8):1204-12
pubmed: 22365939
Int J Environ Res Public Health. 2020 Nov 17;17(22):
pubmed: 33212953
BMC Cancer. 2014 Jul 24;14:535
pubmed: 25060700
J Epidemiol Community Health. 2005 Mar;59(3):231-7
pubmed: 15709084
Health Place. 2010 Jul;16(4):703-11
pubmed: 20399699
Epidemiol Rev. 2002;24(2):190-202
pubmed: 12762092
Scand J Public Health. 2014 May;42(3):245-54
pubmed: 24567425
Stat Med. 2015 Apr 30;34(9):1548-59
pubmed: 25645551
Int J Health Geogr. 2011 Jan 13;10:6
pubmed: 21232096
Health Place. 2013 Nov;24:165-72
pubmed: 24112963
Bayesian Anal. 2017 Mar;12(1):239-259
pubmed: 29707101
Nutrients. 2019 Jul 03;11(7):
pubmed: 31277242
J Urban Health. 2014 Feb;91(1):46-61
pubmed: 23564269
Cancer Epidemiol. 2020 Dec;69:101827
pubmed: 33038640
BMC Public Health. 2016 Jul 29;16:663
pubmed: 27473140
J Urban Health. 2003 Dec;80(4):569-89
pubmed: 14709706
Sci Total Environ. 2020 Mar 25;710:136315
pubmed: 31923678
J Epidemiol Community Health. 2015 May;69(5):432-41
pubmed: 25631857
BMC Public Health. 2013 May 16;13:480
pubmed: 23679869
Prim Care Diabetes. 2017 Oct;11(5):453-460
pubmed: 28623082
Environ Res. 2018 Nov;167:499-505
pubmed: 30142625
Ann N Y Acad Sci. 2010 Feb;1186:125-45
pubmed: 20201871
Environ Res. 2020 Nov;190:109993
pubmed: 32745539
Int J Environ Res Public Health. 2019 Apr 09;16(7):
pubmed: 30970576
Epidemiology. 2001 Sep;12(5):521-31
pubmed: 11505171

Auteurs

Miguel A Martinez-Beneito (MA)

Departament d'Estadística e Investigaciò Opertiva, Universitat de València, 46100 Burjassot, Spain.
CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.

Carlos Vergara-Hernández (C)

FISABIO Foundation, 46020 Valencia, Spain.

Paloma Botella-Rocamora (P)

Dirección General de Salut Pública i Adiccions, Conselleria de Sanitat Universal y Salut Pública, 46020 Valencia, Spain.

Francisca Corpas-Burgos (F)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
FISABIO Foundation, 46020 Valencia, Spain.

Jordi Pérez-Panadés (J)

Dirección General de Salut Pública i Adiccions, Conselleria de Sanitat Universal y Salut Pública, 46020 Valencia, Spain.

Óscar Zurriaga (Ó)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
FISABIO Foundation, 46020 Valencia, Spain.
Dirección General de Salut Pública i Adiccions, Conselleria de Sanitat Universal y Salut Pública, 46020 Valencia, Spain.
Departament de Medicina Preventiva, Salut Pública, Ciències de l'Alimentación, Toxicología i Medicina Legal, Universitat de València, 46010 Valencia, Spain.

Elena Aldasoro (E)

Dirección de Salud Pública y Adicciones, 48013 Bilbao, Spain.

Carme Borrell (C)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), 08025 Barcelona, Spain.

Elena Cabeza (E)

Institut d'investigació sanitària de les Illes Balears, 07120 Palma de Mallorca, Spain.

Lluís Cirera (L)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Department of Epidemiology, Regional Health Council-IMIB-Arrixaca, 30008 Murcia, Spain.

Josu Delfrade Osinaga (J)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain.

Ana Fernández-Somoano (A)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
IUOPA-Medicine Department, Universidad de Oviedo, 33006 Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33001 Oviedo, Spain.

Ana Gandarillas (A)

Consejeria de Sanidad, 28035 Madrid, Spain.

Pedro L Lorenzo Ruano (PL)

Servicio Canario de Salud, 35018 Las Palmas de Gran Canaria, Spain.

Marc Marí-Dell'Olmo (M)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), 08025 Barcelona, Spain.

Andreu Nolasco (A)

Universidad de Alicante, 03690 San Vicente del Raspeig, Spain.

M Dolores Prieto-Salceda (MD)

Fundación Marqués de Valdecilla-Observatorio de Salud Pública de Cantabria, 39008 Santander, Spain.

Rebeca Ramis (R)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Instituto de Salud Carlos III, 28029 Madrid, Spain.

Maica Rodríguez-Sanz (M)

CIBER de Epidemiología y Salud Pública, 28029 Madrid, Spain.
Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), 08025 Barcelona, Spain.

Pablo Sánchez-Villegas (P)

Escuela Andaluza de Salud Pública, 18011 Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH